
Thymic peptide, Toll-like receptor signalling modulator
Thymosin Alpha-1
Thymic peptide, Toll-like receptor signalling modulator. Supplied for laboratory research use only.
- Thymic peptide; approved as Zadaxin in 35+ countries, never FDA
- Largest trial in this catalogue: TESTS, n=1,106, BMJ 2025
- Primary endpoint null: 23.4% vs 24.1% mortality, sepsis
- Supplied for laboratory research use only. Not for human or veterinary use.
90-Day Money-Back Guarantee
Every order is covered for ninety days from delivery. If you decide against it inside that window, contact us and we will refund the purchase price.
Research use only. Not for human or veterinary use or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure or prevent any disease.
What it is
Development status
Thymosin Alpha-1 is not approved by the FDA for any indication.
Development status is stated above. No efficacy claim is made on this page.
Shipping & returns
The specifics
The details, if you want them.
Development
Where it is up to.
Peer-reviewed data, including pivotal randomized trials, underlies its approval as Zadaxin outside the US. No FDA/EMA/MHRA/TGA approval exists.
Questions
The questions people actually ask.
What is thymosin alpha-1?
Is this the same as Zadaxin?
What does "Research Use Only" mean?
How is thymosin alpha-1 supplied?
What is your refund policy?